Essential role for proteinase-activated receptor-2 in arthritis

Authors:
  • JLJohn C. Lockhart
    John C. Lockhart
  • EKElizabeth B. Kelso
    Elizabeth B. Kelso
  • LDLynette Dunning
    Lynette Dunning
  • RPRobin Plevin
    Robin Plevin
  • SMStephen E. Meek
    Stephen E. Meek
  • ASAndrew J.H. Smith
    Andrew J.H. Smith
  • GHGary D. Hunter
    Gary D. Hunter
  • JMJohn S. McLean
    John S. McLean
  • FMFrances McGarry
    Frances McGarry
  • RRRobert Ramage
    Robert Ramage
  • LJLu Jiang
    Lu Jiang

Abstract
Using physiological, pharmacological, and gene disruption approaches, we demonstrate that proteinase-activated receptor-2 (PAR-2) plays a pivotal role in mediating chronic inflammation. Using an adjuvant monoarthritis model of chronic inflammation, joint swelling was substantially inhibited in PAR-2–deficient mice, being reduced by more than fourfold compared with wild-type mice, with virtually no histological evidence of joint damage. Mice heterozygous for PAR-2 gene disruption showed an intermediate phenotype. PAR-2 expression, normally limited to endothelial cells in small arterioles, was substantially upregulated 2 weeks after induction of inflammation, both in synovium and in other periarticular tissues. PAR-2 agonists showed potent proinflammatory effects as intra-articular injection of ASKH95, a novel synthetic PAR-2 agonist, induced prolonged joint swelling and synovial hyperemia. Given the absence of the chronic inflammatory response in the PAR-2–deficient mice, our findings demonstrate a key role for PAR-2 in mediating chronic inflammation, thereby identifying a novel and important therapeutic target for the management of chronic inflammatory diseases such as rheumatoid arthritis.

This publication has 18 references indexed in Scilit: